The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa

The prevalence of human immunodeficiency virus (HIV) drug resistance mutations (DRMs) was estimated in 25 untreated infants who were living with HIV-1, younger than 13 months and living in Senegal. Antiretroviral DRMs were detected in 8 of 25 (32%) children. Non-nucleoside reverse transcriptase inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kébé, Khady, Bélec, Laurent, Ndiaye, Halimatou Diop, Gueye, Sokhna Bousso, Diouara, Abou Abdallah Malick, Ngom, Safiétou, Gueye, Ndéye Rama Diagne, Mbaye, Ngagne, Signaté Sy, Haby, Mboup, Souleymane, Kane, Coumba Touré
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895257/
https://www.ncbi.nlm.nih.gov/pubmed/24439027
http://dx.doi.org/10.7448/IAS.17.1.18526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895257/
https://www.ncbi.nlm.nih.gov/pubmed/24439027
http://dx.doi.org/10.7448/IAS.17.1.18526

Ejemplares similares